LENVIMA

EISAI LIMITED🇨🇦 Health Canada

Approval Id: d39e1838e8e4d3e0
Drug Approval Canada Name: LENVIMA
Product Name: LENVIMA
Status: Marketed
Status Date: 2016-03-31
Original Market Date: 2016-03-31
Din: 02450313
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EX08 LENVATINIB
Atc Name: l 01 ex 08
Aig Number: 0157671003
Company Name: EISAI LIMITED
Company Address: 6925 Century Ave, Suite 701, Mississauga, Ontario, Canada, L5N 7K2
Company Detail Path: /organization/eisai-limited

LENVATINIB (LENVATINIB MESYLATE)

14 MG / DOSE

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d39e1838e8e4d3e0

Type

Standard